Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
2.
Br J Pharmacol ; 173(5): 870-87, 2016 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-26660275

RESUMO

BACKGROUND AND PURPOSE: We investigated the hypothesis that elevated glucose increases contractile responses in vascular smooth muscle and that this enhanced constriction occurs due to the glucose-induced PKC-dependent inhibition of voltage-gated potassium channels. EXPERIMENTAL APPROACH: Patch-clamp electrophysiology in rat isolated mesenteric arterial myocytes was performed to investigate the glucose-induced inhibition of voltage-gated potassium (Kv ) current. To determine the effects of glucose in whole vessel, wire myography was performed in rat mesenteric, porcine coronary and human internal mammary arteries. KEY RESULTS: Glucose-induced inhibition of Kv was PKC-dependent and could be pharmacologically dissected using PKC isoenzyme-specific inhibitors to reveal a PKCß-dependent component of Kv inhibition dominating between 0 and 10 mM glucose with an additional PKCα-dependent component becoming evident at concentrations greater than 10 mM. These findings were supported using wire myography in all artery types used, where contractile responses to vessel depolarization and vasoconstrictors were enhanced by increasing bathing glucose concentration, again with evidence for distinct and complementary PKCα/PKCß-mediated components. CONCLUSIONS AND IMPLICATIONS: Our results provide compelling evidence that glucose-induced PKCα/PKCß-mediated inhibition of Kv current in vascular smooth muscle causes an enhanced constrictor response. Inhibition of Kv current causes a significant depolarization of vascular myocytes leading to marked vasoconstriction. The PKC dependence of this enhanced constrictor response may present a potential therapeutic target for improving microvascular perfusion following percutaneous coronary intervention after myocardial infarction in hyperglycaemic patients.


Assuntos
Vasos Coronários/efeitos dos fármacos , Glucose/farmacologia , Artéria Torácica Interna/efeitos dos fármacos , Artérias Mesentéricas/efeitos dos fármacos , Proteína Quinase C beta/fisiologia , Proteína Quinase C-alfa/fisiologia , Animais , Vasos Coronários/fisiologia , Humanos , Técnicas In Vitro , Isoenzimas/antagonistas & inibidores , Isoenzimas/fisiologia , Masculino , Artéria Torácica Interna/fisiologia , Artérias Mesentéricas/fisiologia , Miócitos de Músculo Liso/efeitos dos fármacos , Miócitos de Músculo Liso/fisiologia , Canais de Potássio de Abertura Dependente da Tensão da Membrana/fisiologia , Proteína Quinase C beta/antagonistas & inibidores , Proteína Quinase C-alfa/antagonistas & inibidores , Ratos Wistar , Suínos , Vasoconstrição/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA